Reduction in snoring with phosphocholinamin, a long-acting tissue-lubricating agent

Am J Otolaryngol. 1987 Jul-Aug;8(4):236-40. doi: 10.1016/s0196-0709(87)80009-1.

Abstract

The efficacy of a long-acting lubricating and coating agent, phosphocholinamin, in reducing snoring was tested in 12 persons, six of whom received the agent as nose drops and six of whom received a placebo (tap water nose drops). In all subjects, the noise level was measured continuously by using a microphone taped near the cricothyroid notch. In the group treated with phosphocholinamin, the maximum nocturnal decibel level was reduced by a mean +/- SD of 13 +/- 3%, and the snoring index (defined as the number of snores per hour of sleep) was reduced by 25 +/- 12%. In the group treated with placebo, the maximum nocturnal decibel level increased 9 +/- 22% and the snoring index increased 1 +/- 20%. The differences between the two groups were statistically significant (P less than .05). It is concluded that phosphocholinamin can provide a useful medical alternative in the treatment of snoring and that further trials of this agent are indicated.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Administration, Intranasal
  • Adult
  • Aged
  • Airway Resistance / drug effects
  • Drug Combinations / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mineral Oil / therapeutic use*
  • Oxygen / blood
  • Phosphatidylcholines / therapeutic use*
  • Sleep Apnea Syndromes / drug therapy
  • Snoring / drug therapy*

Substances

  • Drug Combinations
  • Phosphatidylcholines
  • phosphocholinamin
  • Mineral Oil
  • Oxygen